InvestorsHub Logo

Jonjones325

12/02/21 2:37 PM

#338455 RE: Jonjones325 #338453

Also said we are beyond dose finding work and that too much can actually have an opposite effect. The doses they are using show dose dependent improvements.

FitzyP33

12/02/21 2:51 PM

#338457 RE: Jonjones325 #338453

I agree. Great conference/interview by the analyst.

No one has killed Missling more than me on this MB, but I have to admit that he does know his "stuff" and is very confident in explaining it.

He put on a tie today for the conference - NICE!

I would expect to see coverage from Evercore in the not to distant future. It seems to me that's how these conferences work.

HMB2010

12/02/21 3:03 PM

#338461 RE: Jonjones325 #338453

Absolutely works in avxl favor if doesn't retard approval process even slower.

"and Aduhelm set a precedent"